Drug intelligence / Profile preview

SRP + alendronate

Development stage
Preclinical
Lead developer
Merck
Modality
Small Molecules
Administration
Topical, Oral, Intravenous
01

Overview

SRP + alendronate refers to the combination therapy of scaling and root planing (SRP), a non-pharmacological dental procedure for treating periodontitis, with adjunctive administration of the drug alendronate. Alendronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption, thereby preventing bone breakdown and increasing bone density. In this combination, alendronate can be administered either locally (directly into periodontal sites) or systemically (oral or intravenous). The addition of alendronate to SRP has been shown in meta-analyses to improve clinical outcomes in periodontitis patients compared to SRP alone—specifically by increasing clinical attachment level (CAL), reducing probing depth (PD), and enhancing bone defect fill. Locally delivered alendronate appears more effective than systemic administration for these endpoints. However, systemic use carries risks such as osteonecrosis of the jaw[1][2][4].

Other names
scaling and root planing + alendronateSRP with alendronate
02

Targets

FDPS (Farnesyl pyrophosphate synthase)

Beyond the preview

Go deeper on SRP + alendronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRP + alendronate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call